Chugai Pharmaceutical Co Ltd (CHGCY)
20.69
+0.21
(+1.03%)
USD |
OTCM |
Nov 21, 16:00
Chugai Pharmaceutical Profit Margin (Quarterly): 34.69% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 34.69% |
| June 30, 2024 | 35.41% |
| March 31, 2024 | 31.40% |
| December 31, 2023 | 33.31% |
| September 30, 2023 | 30.08% |
| June 30, 2023 | 31.11% |
| March 31, 2023 | 23.54% |
| December 31, 2022 | 23.37% |
| September 30, 2022 | 30.09% |
| June 30, 2022 | 30.72% |
| March 31, 2022 | 36.57% |
| December 31, 2021 | 30.67% |
| September 30, 2021 | 29.94% |
| June 30, 2021 | 31.94% |
| March 31, 2021 | 28.08% |
| December 31, 2020 | 24.86% |
| September 30, 2020 | 28.85% |
| June 30, 2020 | 26.90% |
| March 31, 2020 | 28.72% |
| December 31, 2019 | 22.65% |
| September 30, 2019 | 25.53% |
| June 30, 2019 | 20.62% |
| March 31, 2019 | 22.70% |
| December 31, 2018 | 14.44% |
| September 30, 2018 | 15.33% |
| Date | Value |
|---|---|
| June 30, 2018 | 15.10% |
| March 31, 2018 | 18.92% |
| December 31, 2017 | 10.59% |
| September 30, 2017 | 15.64% |
| June 30, 2017 | 13.82% |
| March 31, 2017 | 14.74% |
| December 31, 2016 | 8.07% |
| September 30, 2016 | 10.12% |
| June 30, 2016 | 13.36% |
| March 31, 2016 | 12.09% |
| December 31, 2015 | 10.28% |
| September 30, 2015 | 13.72% |
| June 30, 2015 | 12.64% |
| March 31, 2015 | 12.45% |
| December 31, 2014 | 8.81% |
| September 30, 2014 | 9.72% |
| June 30, 2014 | 10.33% |
| March 31, 2014 | 15.14% |
| December 31, 2013 | 10.87% |
| September 30, 2013 | 12.72% |
| June 30, 2013 | 14.33% |
| March 31, 2013 | 9.84% |
| December 31, 2012 | 13.80% |
| September 30, 2012 | 10.10% |
| June 30, 2012 | 11.48% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
22.65%
Minimum
Dec 2019
36.57%
Maximum
Mar 2022
29.65%
Average
30.09%
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 7.83% |
| Nxera Pharma Co Ltd | 12.95% |
| PeptiDream Inc | -5.57% |
| Healios KK | -107.2% |
| AnGes Inc | -2.95K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 21.98% |
| Return on Assets | 20.10% |
| Return on Invested Capital | 23.65% |
| Gross Profit Margin (Quarterly) | 73.32% |
| Operating Margin (Quarterly) | 50.81% |
| Return on Net Operating Assets | 37.79% |